The intestinal microbiota is known to modulate bioavailability and efficacy of endogenous compounds, nutrients or drugs, with large interindividual variations. The least conserved fraction of our microbiota may hence explain a stratification of the human population in converters and non

Using mice models, scientists from UCL and WUR found that Akkermansia muciniphila could have a role in reversing high-fat diet-induced metabolic disorders, in this study obesity and type-2 diabetes. The two first authors, Amandine Everard and Clara Belzer, having respectively

Dr François Leulier on the Biovision Forum 2013

17 May 2013

by GMFH Editing Team

During the Biovision Forum 2013, you chaired the session on the Gut Microbiota and moderated a round table on the subject. What are the main messages coming out of this event?   FL: I think it was an excellent initiative

Some of My Best Friends Are Germs

16 May 2013

by GMFH Editing Team

American journalist Michael Pollan shares his experience with the American Gut Project and gives a full overview on the human microbiome as we know it today. "Here were the names of the hundreds of bacterial species that call me home.

The microbiome and rheumatoid arthritis

13 May 2013

by GMFH Editing Team

Humans are not (and have never been) alone. From the moment we are born, millions of micro-organisms populate our bodies and coexist with us rather peacefully for the rest of our lives. This microbiome represents the totality of micro-organisms (and

Speakers: Giovanni Barbara (Italy), Magnus Simren (Sweden)   Prof. Barbara highlighted the fact that there is increasing evidence indicating that the gut microbiota may be involved in the pathogenesis and pathophysiology of functional gastrointestinal disorders (FGIDs). FGIDs are a group

Moderator: Francisco Guarner – Speakers: Karen Scott, Colin Hill   Karen Scott’s presentation was designed as a pedagogical introduction to the notion of prebiotics. She put forward the definition given in Gibson et al 2010:  “Prebiotics are a selectively fermented

Workshop 4: Dysbiosis in IBD

15 Apr 2013

by GMFH Editing Team

Speakers: Dirk Haller (Germany), Balfour Sartor (USA)   Prof. Haller started his presentation by pointing out that “dysbiosis” is not a good term, because nobody knows what dysbiosis really means. To be able to understand what dysbiosis is, you would

Workshop 5: Faecal microbiota transplantation

15 Apr 2013

by GMFH Editing Team

Speakers: Anne Vrieze (Netherlands), Lawrence Brandt (USA)   Dr Vrieze’s talk focused on faecal microbiota transplantation (FMT) as a therapy for metabolic syndrome and C. difficile inflammation (CDI), under the guiding question whether the lacking diversity of the gut microbiota,